ArticleActa biomaterialia2026
Preconditioned endothelialized grafts reduce stenosis and improve vascular remodeling in a rat pulmonary artery model.
Article in Acta biomaterialia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Pulmonary artery reconstruction is frequently required for congenital heart disease repair, yet current graft options remain limited by the scarcity of autologous conduits and the poor durability of synthetic grafts, which often fail due to thrombosis, stenosis, and calcification. Challenges are exacerbated in the hypoxic, low-pressure pulmonary circulation. Because a functional endothelium is critical for preventing thrombosis and neointimal hyperplasia, we engineered ready-to-use endothelialized tissue-engineered vascular grafts (TEVGs) using a stepwise shear-preconditioning regimen that mimics physiological pulmonary hemodynamics. Human induced pluripotent stem cell-derived endothelial cells (iPSC-ECs) were seeded onto decellularized vascular grafts and conditioned under pulsatile shear stress before implantation. Shear-preconditioned endothelialization improved graft compliance, reduced fibrinogen absorption, and increased endothelial resistance to hypoxic stress in vitro. We then evaluated graft performance in a rat pulmonary artery transplantation model designed to recapitulate the hypoxic and stenosis-prone environment of congenital heart disease. Shear-preconditioned endothelialized grafts maintained patency for one month, supported host cell repopulation, and promoted macrophage-mediated remodeling, whereas all control grafts developed severe stenosis. Patent grafts preserved lung alveolar architecture, while stenotic grafts resulted in exudative lung injury. These findings suggest that shear-preconditioned endothelialization may represent a strategy to generate functional vascular grafts for pulmonary artery reconstruction and establish a physiologically relevant small-animal platform for evaluating TEVG performance in congenital heart diseases. STATEMENT OF SIGNIFICANCE: Limited graft availability and the lack of functional endothelial layer remain key factors contributing to stenosis and graft failure in pulmonary artery reconstruction. Here, we reported development of an endothelialized tissue-engineered vascular graft (TEVG) generated through physiological shear-stress preconditioning to promote endothelial maturation and functional adaptation to the hypoxic, low-pressure pulmonary environment. To evaluate graft performance under physiologically relevant condition, we established a reproducible rat left pulmonary artery transplantation model. Compared with control grafts that developed severe stenosis, shear-preconditioned endothelialized TEVGs maintained luminal patency and showed graft recellularization at one month after implantation. This work presents a shear-preconditioned endothelialization strategy to enhance graft patency and remodeling for pulmonary circulation reconstruction in a physiologically relevant small animal model.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.